Advertisement
Screener

Mersana Therapeutics, Inc. Form D

Mersana Therapeutics, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2014-04-08: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2013-09-27; Total offering amount $14,505,371.
  • 2013-10-09: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2013-09-27; Total offering amount $14,499,542.
  • 2012-08-09: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2012-07-27; Total offering amount $26,999,708.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2014-04-08
D/A
Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2013-09-27$14,505,371$14,505,371$010
2013-10-09Rule 506(b)Equity; OptionToAcquire; SecurityToBeAcquired2013-09-27$14,499,542$4,999,994$9,499,5487
2012-08-09Rule 506Equity; OptionToAcquire; SecurityToBeAcquired2012-07-27$26,999,708$12,500,164$14,499,54412